GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system
HONOLULU--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA™ Sprint, an FDA 510(k) pending 1 ultra-premium wide bore 1.5T high-performance gradient MRI system, at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025. This innovative technology is designed to unlock advanced imaging possibilities in cardiology, oncology and other clinical and research areas.
The need for advanced diagnostics in cardiology and oncology continues to grow, with cardiovascular disease accounting for 32% of global deaths, 2 and cancer accounting for nearly 10 million deaths per year. 3 Meeting this demand with advanced MRI technologies has the potential to make significant impact for cardiology and oncology patients.
With the goal of delivering higher gradient benefits previously attainable on only 3.0T systems, SIGNA Sprint is designed to offer high-performance scanning made simple at 1.5T, with exceptional diffusion imaging, a critical tool in oncology diagnosis and treatment planning. SIGNA Sprint is also designed to equip clinicians and researchers with the ability to expand the current 1.5T boundaries, aiming to enable fast clinical translation and pioneering research.
SIGNA Sprint, with a high-gradient performance of 65/200 per axis for fast imaging and exceptional image quality, is designed to deliver crystal-clear visualization of sub-millimetric structures and deep learning solutions to support diagnostics and treatment response monitoring in oncology patients. This new system supports clinicians' shift to quantitative MRI and a deeper understanding of tissue characteristics, going beyond basic assessment of anatomy. The adoption of deep-learning reconstruction techniques for accelerated cardiac MRI aims to reduce the time and expertise needed to interpret scans and drive consistency and reliability.
'We are driven to push the boundaries of what's possible in MRI with our ultra-premium segment, as our goal is to set a new standard in diagnostic research and precision care that allows for earlier clinical detection and treatment response,' said Kelly Londy, CEO, MR, GE HealthCare. 'We are working to enhance diagnostic capabilities to provide highly accurate imaging with peace of mind for patients. We hope to help clinicians unlock new horizons for research in advanced imaging.'
SIGNA Sprint also is designed to optimize patient comfort, providing a 70cm wide bore space, free-breathing capabilities, and blanket-like AIR ™ Coils to improve the patient experience. This next-generation, high-performance platform is designed to benefit from built-in AI technologies – AIR™ Recon DL, Sonic DL™ and AIR x™ – which enable high-quality imaging even in the most demanding anatomies. SIGNA Sprint aims to support clinician goals of providing precision care through the entire care pathway, from the early diagnostic stage to treatment monitoring.
Latest in MRI advancements to be showcased at ISMRM
GE HealthCare also will showcase the latest advancements in MRI technologies at ISMRM, including:
SIGNA™ MAGNUS: A head-only MR scanner designed to support high resolution, high signal-to-noise ratio, diffusion-weighted imaging, and short scan times. GE HealthCare has demonstrated leadership in high-performance gradient technology with the introduction of HyperG gradients, one of the most efficient gradient coils on the market 4.
Sonic DL™ 3D: Designed to accelerate MRI scans across a wide range of clinical applications, Sonic DL for 3D 5 builds on GE HealthCare's deep learning innovation legacy and the success of AIR Recon DL, which has helped more than 50 million patients to date.
Freelium™: a helium-free sealed 6 magnet platform in development, aims to dramatically reduce liquid helium usage without sacrificing power efficiency, operational security and clinical performance.
Learn more about SIGNA Sprint and other GE HealthCare MRI technologies at the International Society for Magnetic Resonance in Medicine through May 15, in Honolulu, Hawaii, or visit online at gehealthcare.com.
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.
GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™.
1 SIGNA™ Sprint is 510(k) pending at US FDA. Not yet CE marked. Not available for sale in any region.
2 World Health Organization(2025). CVDs statistics and treatment. World Health Organization. Retrieved from https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
3 World Health Organization. (2025). Cancer statistics and treatment. World Health Organization. Retrieved from https://www.who.int/news-room/fact-sheets/detail/cancer
4 SIGNA™ MAGNUS is 510(k) cleared with the FDA. Not CE Marked. Not available for sale in all regions. GE HealthCare data on file.
5 Sonic DL for 3D is 510(k) pending at the US FDA. Not yet CE Marked. Not available for sale in all regions.
6 Helium-free: Helium is permanently enclosed in the magnet. Technology in development that represents ongoing research and development efforts. Not for sale. Not CE marked. Not cleared or approved by the US FDA or any other global regulator for commercial availability.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Peloton looks to place equipment in gyms, launch marketplace, TechCrunch says
Peloton (PTON) CEO Peter Stern said the company is exploring ways to expand its customer base by making its products available for use in gyms and launching a peer-to-peer marketplace for equipment, Ivan Mehta of TechCrunch reports, citing comments made by Stern at the Bloomberg Tech Summit. Peloton plans to distribute its machines to commercial gyms via is subsidiary Precor and will add Peloton workouts to compatible Precor equipment. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on PTON: Disclaimer & DisclosureReport an Issue Peloton's Strategic Initiatives and Margin Improvements Justify Buy Rating Peloton Interactive call volume above normal and directionally bullish Peloton's 'Repowered' Marketplace: A Strategic Move to Boost Revenue and Brand Loyalty Repowered: Peloton Stock (NASDAQ:PTON) Ticks Up with New Used Market Peloton price target lowered to $8.50 from $10 at Citi Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Broadcom Sinks as CEO Becomes Defensive on AI Opportunity -- Should Investors Buy the Dip?
Broadcom shares fell despite another strong quarter of AI revenue growth. However, its CEO got defensive when asked about the AI market opportunity he touted only six months ago. Still, the company is only at the beginning of its custom AI chip opportunity. 10 stocks we like better than Broadcom › Broadcom (NASDAQ: AVGO) once again reported robust artificial intelligence (AI) revenue growth in its fiscal second-quarter results released this week, with promises that the strong revenue growth would continue. The stock slipped despite an upbeat outlook, although it remains up more than 75% over the past year. Let's take a closer look at Broadcom's most recent results and the AI opportunity in front of it to see whether investors should buy this small dip. Broadcom CEO Hock Tan initially got investors excited back in December 2024 when he talked about the company having a $60 billion to $90 billion serviceable addressable market (SAM) opportunity in fiscal year 2027 with its three largest hyperscale (meaning they operate huge data centers) customers. However, when asked whether its SAM had increased, Tan told analysts he's "not playing the SAM game" and to "stop talking about SAM now." It was an unusual and defensive response from an executive who, only six months ago, was hyping Broadcom's SAM opportunity. However, Tan had said earlier that he anticipates Broadcom's current AI semiconductor revenue growth to sustain into fiscal 2026 after projecting it would grow by 60% to $5.1 billion in fiscal Q3. As one analyst on the call pointed out, that would imply $30 billion or more in AI semiconductor revenue in fiscal 2026. Much of Broadcom's AI semiconductor revenue growth is currently coming from its networking portfolio, particularly Ethernet switches. The company said its AI networking revenue surged by 170% year over year and represented 40% of its AI revenue. Perhaps, the bigger opportunity, though, is in custom AI chips. The company stated that custom AI chip revenue rose by double digits in the quarter and that it expects demand in the back half of 2026 to accelerate as inference demand surges. This is most likely coming from Alphabet, which was Broadcom's first customer for custom AI chips. However, the company said it still expects its three largest custom chip customers to each deploy 1 million AI chip clusters in 2027, mostly for training foundational AI models. Turning to Broadcom's results, its overall revenue climbed 20% year over year to $15 billion in the quarter, while adjusted earnings per share (EPS) soared 44% to $1.58 (adjusting for its prior 10-for-1 stock split). The results edged past analyst expectations for adjusted EPS of $1.56 on revenue of $14.99 billion, as compiled by LSEG. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), meanwhile, surged 67% year over year to $10 billion. AI-related revenue jumped 46% year over year to $4.4 billion. Total semiconductor solutions revenue rose 17% year over year to $8.4 billion, as the recovery in its non-AI chip revenue continues to be slow. Infrastructure software revenue, meanwhile, increased by 25% to $6.6 billion. The company credited the growth to strong sales of its VMware Cloud Foundation (VCF) platform and the transition of customers to subscription models. Its VCF platform helps customers create hybrid and multicloud environments, giving them the flexibility to manage workloads across both public clouds and their own on-premise data centers. Approximately 87% of VMware's top 10,000 customers have now adopted its VCF platform. Broadcom continues to generate strong cash flow, with cash flow from operations coming in at nearly $6.6 billion and free cash flow of $6.4 billion. It ended the quarter with nearly $9.5 billion in cash and equivalents and $67.3 billion in debt after buying back $4.2 billion worth of shares in the quarter. Its debt is a result of its $69 billion acquisition of VMware in 2023. Looking ahead, Broadcom forecasts fiscal Q3 revenue to increase by 21% to $15.8 billion, with semiconductor revenue rising 25% to $9.1 billion and infrastructure software revenue increasing 16% to $6.7 billion. It expects adjusted EBITDA to be about 66% of revenue, or about $10.4 billion. Broadcom continues to see strong AI revenue growth, led by its networking portfolio. But the best opportunity may still be in front of the company, with its custom AI chips. Only Alphabet is truly ramped up, and it has a huge opportunity with other customers. Now, Tan's sudden reluctance to talk about Broadcom's AI semiconductor SAM is disappointing, and the extent to which China's ByteDance -- one of its suspected in-progress large AI chip customers -- and the new Chinese export controls might have on that is unknown. Still, he did not back down from the growth of the company's three large hyperscale customers or that they plan to each deploy 1 million AI chip clusters in 2027. He also still has Apple as well as other customers that aren't quite as far along, which should also power growth in later years. From a valuation perspective, Broadcom now trades at a forward price-to-earnings (P/E) ratio of about 31.5, based on fiscal 2026 analyst estimates, and a price/earnings-to-growth ratio (PEG) of less than 0.4. Stocks with PEG ratios below 1 are generally considered undervalued. Given the growth opportunities still in front of it, I think investors can use this price dip to start building positions. The biggest risk would be a slowdown in spending on AI infrastructure, but we still appear to be in the early innings. Before you buy stock in Broadcom, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Broadcom wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Geoffrey Seiler has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet and Apple. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy. Broadcom Sinks as CEO Becomes Defensive on AI Opportunity -- Should Investors Buy the Dip? was originally published by The Motley Fool
Yahoo
an hour ago
- Yahoo
Is this the Tesla stock buying opportunity I've been waiting for?
Down by 22% in little over a week, Tesla (NASDAQ:TSLA) sometimes seems to be behaving more like a penny share than a company worth almost $900bn that last year had a revenue close to $100bn. Still, I have been eyeing Tesla stock as a possible addition to my portfolio for a while already – so could this latest crash offer me the sort of buying opportunity I have been hoping for? My answer depends on the price, something I will get into below. First, though, I ought to explain why I like the idea of owning some Tesla stock at all. The company is barely more than two decades old. But it has already built up a massive global manufacturing and sales footprint for its electric vehicles. Sales volumes declined slightly last year (and that decline has accelerated this year), but remain substantial. I think Tesla's recent history points to two important factors. First, it is a serious contender in the electric vehicle space. That is a competitive area and Tesla risks rivals like BYD leaving it behind, but it has strengths such as proprietary technology, a vertically integrated business model and unique designs. A second point also jumps out at me from Tesla's development. It has demonstrated expertise not only in imagining new products, but in bringing them to market at scale and quickly. It is doing the same now with its power storage division, which, unlike the car business, had a very strong first quarter. Such expertise could help Tesla capitalize on some of the other ideas that sit somewhere between its drawing board and widespread real world use, from automated taxi fleets to robotics. That matters because, seen purely as a car company, Tesla stock would look wildly overvalued to me. As far as I am concerned, the only possible justification for the current valuation, let alone a higher one, is the potential of the company's plans beyond the electric car business. That, however, is where I start to have serious concerns about valuation, even after the recent crash in Tesla stock. While the power storage business is growing quickly, even taken together with the car business I do not think the joint valuation ought to be anywhere close to $900bn. Meanwhile, the other ideas are highly speculative for now – it remains to be seen when they are commercialized at scale, if they ever are. So I think it is hard to justify anything more than a fairly modest valuation for them at this point, no matter how large the long-term potential may seem to be. Taken as the sum of the parts, I do not think Tesla is worth anything like its market capitalization. So, although the share is cheaper than a couple of weeks back, it is still far too expensive for me to consider buying yet. The post Is this the Tesla stock buying opportunity I've been waiting for? appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool C Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
